Global Biologics CDMO Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	158 Pages	TechNavio	February, 2023	INF17761532

Best Price Guarantee
Price	from $2,500
Length	158 Pages
Publisher	TechNavio
Published Date	February, 2023
SKU	INF17761532

Global Biologics CDMO Market 2023-2027

Technavio has been monitoring the biologics CDMO market and is forecast to grow by $13.26 bn during 2022-2027, accelerating at a CAGR of 13.97% during the forecast period. Our report on the biologics CDMO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of cost-efficient resources in emerging markets, strong research and development pipeline of biologics therapeutics, and a growing need to focus on core competencies.

Technavio's biologics CDMO market is segmented as below:

By Type

Mammalian
Microbial

By Product Type

Biologics
Biosimilars

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advent of big data as one of the prime reasons driving the biologics CDMO market growth during the next few years. Also, strategic alliances and partnerships with pharma companies and increasing approvals for new molecules and biosimilars will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biologics CDMO market covers the following areas:

Biologics CDMO market sizing
Biologics CDMO market forecast
Biologics CDMO market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biologics CDMO market vendors that include 3P BIOPHARMACEUTICALS S.L.U., AbbVie Inc., AGC Biologics, Binex Co. Ltd., Boehringer Ingelheim International GmbH, Bora Pharmaceuticals Co. Ltd., Catalent Inc., Cytovance Biologics, Evonik Industries AG, FUJIFILM Holdings Corp, Grifols SA, JRS PHARMA GmbH and Co. KG, JSR Corp., Kemwell Biopharma Pvt. Ltd., KLOCKE GROUP, Lonza Group Ltd., Novartis AG, Rentschler Biopharma SE, Samsung Biologics Co. Ltd., Toyobo Co. Ltd., and WuXi Biologics Cayman Inc. Also, the biologics CDMO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary – Chart on Market Overview
  - Table Executive Summary – Data Table on Market Overview
  - Table Executive Summary – Chart on Global Market Characteristics
  - Table Executive Summary – Chart on Market by Geography
  - Table Executive Summary – Chart on Market Segmentation by Type
  - Table Executive Summary – Chart on Market Segmentation by Product Type
  - Table Executive Summary – Chart on Incremental Growth
  - Table Executive Summary – Data Table on Incremental Growth
  - Table Executive Summary – Chart on Vendor Market Positioning
Market Landscape
- Market ecosystem
  - Table Parent market
  - Table Market Characteristics
Market Sizing
- Market definition
  - Table Offerings of vendors included in the market definition
- Market segment analysis
  - Table Market segments
- Market size 2022
- Market outlook: Forecast for 2022-2027
  - Table Chart on Global - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Global - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Global Market: Year-over-year growth 2022-2027 (%)
  - Table Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Historic Market Size
- Global biologics CDMO market 2017 - 2021
  - Table Historic Market Size – Data Table on Global biologics CDMO market 2017 - 2021 ($ billion)
- Type Segment Analysis 2017 - 2021
  - Table Historic Market Size – Type Segment 2017 - 2021 ($ billion)
- Product type Segment Analysis 2017 - 2021
  - Table Historic Market Size – Product type Segment 2017 - 2021 ($ billion)
- Geography Segment Analysis 2017 - 2021
  - Table Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
- Country Segment Analysis 2017 - 2021
  - Table Historic Market Size – Country Segment 2017 - 2021 ($ billion)
Five Forces Analysis
- Five forces summary
  - Table Five forces analysis - Comparison between 2022 and 2027
- Bargaining power of buyers
  - Table Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- Bargaining power of suppliers
  - Table Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- Threat of new entrants
  - Table Threat of new entrants – Impact of key factors in 2022 and 2027
- Threat of substitutes
  - Table Threat of substitutes – Impact of key factors in 2022 and 2027
- Threat of rivalry
  - Table Threat of rivalry – Impact of key factors in 2022 and 2027
- Market condition
  - Table Chart on Market condition - Five forces 2022 and 2027
Market Segmentation by Type
- Market segments
  - Table Chart on Type - Market share 2022-2027 (%)
  - Table Data Table on Type - Market share 2022-2027 (%)
- Comparison by Type
  - Table Chart on Comparison by Type
  - Table Data Table on Comparison by Type
- Mammalian - Market size and forecast 2022-2027
  - Table Chart on Mammalian - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Mammalian - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Mammalian - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Mammalian - Year-over-year growth 2022-2027 (%)
- Microbial - Market size and forecast 2022-2027
  - Table Chart on Microbial - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Microbial - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Microbial - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Microbial - Year-over-year growth 2022-2027 (%)
- Market opportunity by Type
  - Table Market opportunity by Type ($ billion)
Market Segmentation by Product Type
- Market segments
  - Table Chart on Product Type - Market share 2022-2027 (%)
  - Table Data Table on Product Type - Market share 2022-2027 (%)
- Comparison by Product Type
  - Table Chart on Comparison by Product Type
  - Table Data Table on Comparison by Product Type
- Biologics - Market size and forecast 2022-2027
  - Table Chart on Biologics - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Biologics - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Biologics - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Biologics - Year-over-year growth 2022-2027 (%)
- Biosimilars - Market size and forecast 2022-2027
  - Table Chart on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Biosimilars - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Biosimilars - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Biosimilars - Year-over-year growth 2022-2027 (%)
- Market opportunity by Product Type
  - Table Market opportunity by Product Type ($ billion)
Customer Landscape
- Customer landscape overview
  - Table Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Geographic Landscape
- Geographic segmentation
  - Table Chart on Market share by geography 2022-2027 (%)
  - Table Data Table on Market share by geography 2022-2027 (%)
- Geographic comparison
  - Table Chart on Geographic comparison
  - Table Data Table on Geographic comparison
- North America - Market size and forecast 2022-2027
  - Table Chart on North America - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on North America - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on North America - Year-over-year growth 2022-2027 (%)
  - Table Data Table on North America - Year-over-year growth 2022-2027 (%)
- Europe - Market size and forecast 2022-2027
  - Table Chart on Europe - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Europe - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Europe - Year-over-year growth 2022-2027 (%)
- Asia - Market size and forecast 2022-2027
  - Table Chart on Asia - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Asia - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Asia - Year-over-year growth 2022-2027 (%)
- Rest of World (ROW) - Market size and forecast 2022- 2027
  - Table Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- US - Market size and forecast 2022-2027
  - Table Chart on US - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on US - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on US - Year-over-year growth 2022-2027 (%)
  - Table Data Table on US - Year-over-year growth 2022-2027 (%)
- China - Market size and forecast 2022-2027
  - Table Chart on China - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on China - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on China - Year-over-year growth 2022-2027 (%)
  - Table Data Table on China - Year-over-year growth 2022-2027 (%)
- Germany - Market size and forecast 2022-2027
  - Table Chart on Germany - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Germany - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Germany - Year-over-year growth 2022-2027 (%)
- France - Market size and forecast 2022-2027
  - Table Chart on France - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on France - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on France - Year-over-year growth 2022-2027 (%)
  - Table Data Table on France - Year-over-year growth 2022-2027 (%)
- Japan - Market size and forecast 2022-2027
  - Table Chart on Japan - Market size and forecast 2022-2027 ($ billion)
  - Table Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
  - Table Chart on Japan - Year-over-year growth 2022-2027 (%)
  - Table Data Table on Japan - Year-over-year growth 2022-2027 (%)
- Market opportunity by geography
  - Table Market opportunity by geography ($ billion)
Drivers, Challenges, and Trends
- Market drivers
  - Availability of cost-efficient resources in emerging markets
  - Strong research and development pipeline of biologics therapeutics
  - Growing need to focus on core competencies
- Market challenges
  - Capacity utilization and constraints
  - Stringent policies related to entry of new biologics
  - Serialization issues faced by CDMOs due to multiple production lines
- Impact of drivers and challenges
  - Table Impact of drivers and challenges in 2022 and 2027
- Market trends
  - Advent of big data
  - Strategic alliances and partnerships with pharma companies
  - Increasing approvals for new molecules and biosimilars
Vendor Landscape
- Overview
- Vendor landscape
  - Table Overview on Criticality of inputs and Factors of differentiation
- Landscape disruption
  - Table Overview on factors of disruption
- Industry risks
  - Table Impact of key risks on business
Vendor Analysis
- Vendors covered
  - Table Vendors covered
- Market positioning of vendors
  - Table Matrix on vendor position and classification
- AbbVie Inc.
  - Table AbbVie Inc. - Overview
  - Table AbbVie Inc. - Product / Service
  - Table AbbVie Inc. - Key news
  - Table AbbVie Inc. - Key offerings
- Binex Co. Ltd.
  - Table Binex Co. Ltd. - Overview
  - Table Binex Co. Ltd. - Product / Service
  - Table Binex Co. Ltd. - Key offerings
- Boehringer Ingelheim International GmbH
  - Table Boehringer Ingelheim International GmbH - Overview
  - Table Boehringer Ingelheim International GmbH - Business segments
  - Table Boehringer Ingelheim International GmbH - Key news
  - Table Boehringer Ingelheim International GmbH - Key offerings
  - Table Boehringer Ingelheim International GmbH - Segment focus
- Bora Pharmaceuticals Co. Ltd.
  - Table Bora Pharmaceuticals Co. Ltd. - Overview
  - Table Bora Pharmaceuticals Co. Ltd. - Product / Service
  - Table Bora Pharmaceuticals Co. Ltd. - Key offerings
- Catalent Inc.
  - Table Catalent Inc. - Overview
  - Table Catalent Inc. - Business segments
  - Table Catalent Inc. - Key news
  - Table Catalent Inc. - Key offerings
  - Table Catalent Inc. - Segment focus
- Evonik Industries AG
  - Table Evonik Industries AG - Overview
  - Table Evonik Industries AG - Business segments
  - Table Evonik Industries AG - Key news
  - Table Evonik Industries AG - Key offerings
  - Table Evonik Industries AG - Segment focus
- FUJIFILM Holdings Corp
  - Table FUJIFILM Holdings Corp - Overview
  - Table FUJIFILM Holdings Corp - Business segments
  - Table FUJIFILM Holdings Corp - Key offerings
  - Table FUJIFILM Holdings Corp - Segment focus
- Grifols SA
  - Table Grifols SA - Overview
  - Table Grifols SA - Business segments
  - Table Grifols SA - Key offerings
  - Table Grifols SA - Segment focus
- JRS PHARMA GmbH and Co. KG
  - Table JRS PHARMA GmbH and Co. KG - Overview
  - Table JRS PHARMA GmbH and Co. KG - Product / Service
  - Table JRS PHARMA GmbH and Co. KG - Key offerings
- Lonza Group Ltd.
  - Table Lonza Group Ltd. - Overview
  - Table Lonza Group Ltd. - Business segments
  - Table Lonza Group Ltd. - Key news
  - Table Lonza Group Ltd. - Key offerings
  - Table Lonza Group Ltd. - Segment focus
- Novartis AG
  - Table Novartis AG - Overview
  - Table Novartis AG - Business segments
  - Table Novartis AG - Key offerings
  - Table Novartis AG - Segment focus
- Rentschler Biopharma SE
  - Table Rentschler Biopharma SE - Overview
  - Table Rentschler Biopharma SE - Product / Service
  - Table Rentschler Biopharma SE - Key offerings
- Samsung Biologics Co. Ltd.
  - Table Samsung Biologics Co. Ltd. - Overview
  - Table Samsung Biologics Co. Ltd. - Product / Service
  - Table Samsung Biologics Co. Ltd. - Key offerings
- Toyobo Co. Ltd.
  - Table Toyobo Co. Ltd. - Overview
  - Table Toyobo Co. Ltd. - Business segments
  - Table Toyobo Co. Ltd. - Key offerings
  - Table Toyobo Co. Ltd. - Segment focus
- WuXi Biologics Cayman Inc.
  - Table WuXi Biologics Cayman Inc. - Overview
  - Table WuXi Biologics Cayman Inc. - Product / Service
  - Table WuXi Biologics Cayman Inc. - Key offerings
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
  - Table Inclusions checklist
  - Table Exclusions checklist
- Currency conversion rates for US$
  - Table Currency conversion rates for US$
- Research methodology
  - Table Research methodology
  - Table Validation techniques employed for market sizing
  - Table Information sources
- List of abbreviations
  - Table List of abbreviations